FormuTech Summit 2026

14th October 2026 - 15th October 2026

The FormuTech Summit brings together over 80+ senior industry experts, uniting leaders in the pharmaceutical and biotechnology sectors, as well as academia, to redefine mRNA process development, LNP formulations, and manufacturing.

Key topics include empowering mRNA advancements to ensure efficiency and therapeutic relevance, mastering LNP characterization for enhanced efficacy and safety, and overcoming global manufacturing challenges to build a resilient production landscape.

World Patient Safety Congress Americas 2026

13th October 2026 - 15th October 2026

The World Patient Safety Congress Americas (formerly known as World Drug Safety Congress Americas) is the premier global marketplace for C-suite executives, R&D specialists, and data leaders to define the future of pharmacovigilance and patient safety.

Taking place from October 13-15, 2026, at the Thomas M.Menino Convention & Exhibition Center, Boston, this event explores the intersection of drug safety strategy and technological disruption.

This premier event brings together over 1,800 leaders from pharma, biotech, and regulatory bodies to explore the future of pharmacovigilance.

The congress features over 250 speakers and 10 content tracks focusing on the role of AI, automation, and Real-World Evidence (RWE) in safety monitoring and risk management.

By bringing together international regulatory bodies, industry professionals, and patient representatives, the event aims to foster a collaborative culture of innovation that improves safety outcomes across pharmaceutical drugs, medical devices, and consumer products.

Festival of Biologics Basel 2026

13th October 2026 - 15th October 2026

The Festival of Biologics Basel is Europe’s largest biologics event, covering the start-to-finish of the industry in antibody therapies, cell and gene therapies, immunotherapies and biosimilars.

Designed for industry experts in pharma and biotech, start-ups, academics, regulators and investors, the Festival of Biologics is the meeting place for the large molecule therapy ecosystem, bringing together 3000+ attendees.

17th World ADC San Diego 2026

12th October 2026 - 15th October 2026

Connecting every corner of the ADC ecosystem, the 17th World ADC San Diego is the definitive meeting place for the global bioconjugate community.

Bringing together 1,300+ senior leaders from pharma, biotech, start-ups, academia and service providers, the event delivers an unparalleled mix of data, insights and networking.

Across seven dedicated tracks spanning discovery through to manufacturing, attendees gain practical strategies to de-risk development and accelerate ADCs into earlier lines of treatment.

Featuring cutting-edge case studies, emerging trends and high-value connections, this is the must-attend event for anyone looking to stay at the forefront of ADC innovation.

Biologics World South East Asia 2026

14th October 2026 - 15th October 2026

Biologics World Southeast Asia is a premier regional platform dedicated to advancing the development, manufacturing, and commercialisation of therapeutic biologics across ASEAN.

The conference convenes senior leaders from biopharma, biotech, CDMOs, academia, regulators, investors, and technology providers to address the strategic opportunities shaping Southeast Asia’s biologics landscape.

As demand for monoclonal antibodies, biosimilars, and next-generation biologics continues to rise across the region, Southeast Asia is emerging as a critical hub for clinical development, manufacturing expansion, and healthcare innovation.

Governments across Singapore, Malaysia, Thailand, Indonesia, Vietnam, and the wider ASEAN region are accelerating investments into life sciences infrastructure, regulatory strengthening, and local production capabilities to enhance healthcare resilience and reduce reliance on imports. The conference explores the full therapeutic biologics value chain — from R&D and translational science to bioprocessing, manufacturing scale-up, CDMO partnerships, and market access.

Through strategic discussions and real-world case studies, the programme highlights regional capabilities, investment priorities, and collaboration opportunities driving the growth of biologics adoption in Southeast Asia.

Vaccine World Asia Congress 2026 – South East Asia

14th October 2026 - 15th October 2026

Building on the momentum of its successful edition, 8th Vaccine World Asia – Southeast Asia 2026 returns as the region’s most influential gathering for vaccine leaders, with a dedicated spotlight on Indonesia and the broader SEA vaccine ecosystem.

As SEA experiences rising vaccine demand driven by persistent public health challenges—including dengue, hepatitis, tuberculosis, influenza, and emerging infectious diseases—governments are boosting investments in immunization programs, manufacturing capabilities, and resilient supply chains. Indonesia, one of the region’s largest and fastest-growing vaccine markets, continues to scale its national immunization efforts, strengthen domestic production, and advance collaborations to achieve vaccine self-sufficiency.

At the same time, SEA faces ongoing barriers such as fragmented regulatory pathways, supply chain bottlenecks, cold-chain limitations, decentralized healthcare infrastructure, and pockets of vaccine hesitancy—especially across rural and remote areas.

Rapidly evolving technologies such as mRNA, recombinant platforms, viral vectors, thermostable formulations, and improved delivery systems are reshaping the region’s vaccine landscape, offering new pathways to bridge immunization gaps and enhance outbreak preparedness. 8th Vaccine World Asia Congress 2026 – Southeast Asia emerges as the go-to strategic event for vaccine leaders across SEA.

The congress will spotlight critical pathways for unlocking regional growth, including strengthening domestic manufacturing, improving cross-border regulatory harmonization, expanding vaccination coverage, accelerating innovation in universal and next-generation vaccines, and modernizing production through digitalized, cost-efficient processes.

By convening leading policymakers, manufacturers, researchers, global health organizations, and technology partners, the event serves as a catalyst for reshaping the future of vaccine development and immunization delivery throughout SEA.

World Vaccine Congress Europe 2026

19th October 2026 - 21st October 2026

The World Vaccine Congress Europe will bring together more than 2,000 attendees, 280 speakers and over 150 exhibitors and start-ups for a comprehensive exploration of the vaccine ecosystem.

The event features presentations from leading global organizations including WHO, PATH, GSK, Moderna and CEPI, alongside panel debates addressing key scientific and policy challenges.

Attendees can benefit from extensive networking through dedicated breaks and receptions, connect with solution providers in a broad exhibition area, and engage in a dynamic start-up zone designed to link innovators with investors seeking promising early-stage vaccine technologies and fostering collaboration across the global vaccine community for progress.

Discount code: BPA20

5th Operationalise: Early Access Programmes Summit Europe 2026

19th October 2026 - 21st October 2026

Early Access Programmes have evolved into a critical, but increasingly complex, part of drug development and launch strategy. What was once a reactive pathway is now a strategic lever shaping timelines, evidence generation, and patient access across global markets.

The 5th Operationalise: Early Access Programmes Summit Europe is built for the teams responsible for turning that strategy into execution. As regulatory expectations shift, reimbursement timelines extend, and programmes scale globally, organisations must make more decisions, earlier, and with greater consequence.

This is the only European forum dedicated to the operational reality of early access – bringing together 140+ leaders across Medical Affairs, Access, Regulatory, Clinical Operations, and Supply to share how programmes are being designed, adapted, and delivered in practice.

Whether you are building your first programme, scaling across regions, or managing a global access portfolio, this is your opportunity to benchmark your approach, challenge your assumptions, and leave with the insight needed to make smarter decisions and deliver earlier, sustainable access for patients in 2026 and beyond.

4th Regenerative Medicine ASRM Congress 2026

23rd October 2026 - 24th October 2026

Regenerative Medicine ASRM Congress is the region’s premier platform dedicated to advancing regenerative medicine, cellular therapies, and next-generation healthcare solutions.

Bringing together clinicians, researchers, scientists, healthcare leaders, innovators, and industry stakeholders, the congress explores the latest developments in stem cell therapy, tissue engineering, gene editing, exosome research, AI-driven healthcare, and personalized medicine.

Through expert-led presentations, scientific discussions, hands-on learning, and networking opportunities, the event bridges the gap between research, clinical practice, regulation, and commercialization.

It serves as a catalyst for collaboration, knowledge exchange, and innovation, helping shape the future of regenerative medicine and improve patient outcomes worldwide.

World Orphan Drug Congress Europe 2026

26th October 2026 - 28th October 2026

The is the world’s leading conferences dedicated to orphan drugs and rare diseases. Taking place from 26–28 October 2026 at the RAI Convention Centre in Amsterdam, the event will bring together more than 1,800 industry leaders, 250+ expert speakers, and over 100 exhibitors from across the global healthcare and biotech sectors.

The congress focuses on key areas such as cell and gene therapy, genetic testing, regulatory strategy, market access, patient advocacy, and real-world evidence.

It provides a major platform for networking, collaboration, and innovation, uniting pharmaceutical companies, researchers, regulators, investors, and patient organisations to advance treatments for rare diseases worldwide.

3rd Raw Materials for Cell & Gene Therapy Summit 2026

26th October 2026 - 28th October 2026

Following the sunshine to San Diego, the 3rd Raw Materials for Cell & Gene Therapy Summit is the only dedicated forum designed to help you take control of raw material risk by uncovering practical, phase-appropriate strategies to manage variability, strengthen supplier qualification, and build scalable frameworks from early development through to commercial manufacturing.

By joining leading experts across quality, MSAT, supply chain, and process development, you will engage in face-to-face discussions on how peers are defining material specifications, managing lot-to-lot variability, and making critical qualification decisions under real development pressure.

Expect a highly collaborative environment where you can challenge assumptions, validate your approach, and leave better equipped to make confident raw material decisions for your program.

 9th TPD & Induced Proximity Summit 2026

26th October 2026 - 29th October 2026

The 9th TPD & Induced Proximity Summit is returning as the globe’s definitive forum to help you gain that ever-important clinical validation.

As the world’s largest and most comprehensive TPD conference featuring the latest data from early discovery to clinical development, it is designed to help you discover the best novel targets, optimize your degrader profile, attract funding and partnerships, and accelerate your pipelines to the clinic and beyond.

Uniting leaders from the likes of Arvinas, Revolution Medicines, Foghorn Therapeutics, BMS,  Amgen, C4 Therapeutics, Neomorph and more, this end-to-end forum is designed to equip you with the data, insights and connections to advance your own induced proximity pipeline and transform therapeutic strategies across oncology, immunology and neurodegeneration.

The AI Drug Discovery & Development Summit 2026

27th October 2026 - 29th October 2026

AI is no longer a research project. It is in your pipeline, your trials, and your competitive landscape right now.

The AI Drug Discovery & Development Summit is where the practitioners deploying it – across every stage of the drug development value chain – come to share what is working, confront what is not, and gain the intelligence to move faster.

1,000+ attendees. 100% of the top 50 pharma companies. Three days of deployment-ready strategies from target identification to clinic.

TIDES Europe 2026

03rd November 2026 - 05th November 2026

Join TIDES Europe 2026, Europe’s biggest event for oligonucleotides, peptides, mRNA, and drug delivery, from November 3-5 in Amsterdam. Meet with 900+ industry experts, gain insights from 100+ expert speakers, explore 90+ exhibitors, and attend immersive workshops.

Discover cutting-edge strategies in discovery, development, and manufacturing to accelerate therapeutics to market. Save 10% at checkout using “BioPharmaAsia10”.

Advanced Therapies USA 2026

04th November 2026 - 05th November 2026

The Advanced Therapies Congress is America’s most exciting cell and gene therapy conference and exhibition.

The conference brings together a community of 1,200 global executives at the Hynes Convention Center, Boston, to be inspired by 200 speakers and 50 start-ups over 2 incredible days.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development; forward-thinking pharma, biotech and start-up companies, researchers, clinicians, academics, HTAs, payers and regulators.

Cell & Gene Therapy International Europe 2026

03rd November 2026 - 05th November 2026

Join Cell & Gene Therapy International Europe 2026 from 3-5 November at Hotel Palace Berlin to explore the future of advanced therapies.

This premier event brings together 300+ global experts to address the industry’s most pressing challenges: scaling manufacturing, reducing costs, and accelerating regulatory pathways.

Discover breakthrough innovations across autologous, allogeneic, and AAV therapies while gaining actionable insights from industry leaders at Novartis, Johnson & Johnson, UCB Pharma, and more.

Explore smart manufacturing technologies including AI, automation, and next-generation analytics that are transforming production efficiency. Your registration includes full access to two co-located events—Exosomes Europe and LNP Delivery—plus live lab demos, investor panels, and exclusive networking opportunities.

Whether you’re in R&D, manufacturing, regulatory affairs, or investment, this is where theory meets industrial reality.

3rd ADC Payload Summit 2026

04th November 2026 - 06th November 2026

The 3rd ADC Payload Summit is the only industry-led meeting dedicated exclusively to advancing ADC payload innovation.

Taking place November 4-6, 2026, in Boston, the summit will bring together 70+ experts across payload discovery, medicinal chemistry, biology, translational science, toxicology, and ADC development to address the key challenges shaping the future of antibody-drug conjugates.

Attendees will gain insights into novel payload mechanisms, dual-payload ADC strategies, resistance biology, therapeutic index optimization, and clinical translation from leading organizations including AstraZeneca, AbbVie, GSK, Takeda, GeneQuantum Healthcare, Hexagon Bio, and Callio Therapeutics, while building valuable connections with peers driving the next generation of ADC innovation.

Global RESCON Summit 2026

10th November 2026 - 11th November 2026

The Global RESCON Summit is a prestigious and highly anticipated event, building on the success of previous editions in New York, Porto, Barcelona, and San Francisco.

Dedicated to Inhalation & Respiratory Drug Delivery | Connected Devices, the summit brings together world-leading experts from the pharmaceutical and biotechnology sectors, device manufacturers, material innovators, and academia.

BIO-Europe 2026

09th November 2026 - 11th November 2026

The premier global biopharma partnering event unveils a bold new vision for its 32nd annual conference in Cologne, Germany, November 9-11, 2026.

BIO-Europe is evolving beyond Europe’s largest partnering event to become the neutral forum where the biopharma C-suite shapes partnerships and industry strategy worldwide.

As the sector faces increasing complexity across regulation, clinical development, manufacturing, policy, and financing, the 2026 conference expands to convene C-level executives through seven integrated tracks and high-impact plenary sessions.

The enhanced programme delivers strategy-focused content spanning regulatory, clinical, manufacturing, dealmaking, therapeutic areas, and ecosystem streams, fuelling dialogue among decision-makers across the global life sciences value chain.

11th Microbiome Movement USA Summit 2026

09th November 2026 - 11th November 2026

The 11th Microbiome Movement USA Summit is the leading industry forum dedicated to advancing microbiome-based therapeutics from scientific discovery to clinical and commercial success.

Bringing together senior leaders from biopharma, biotech, investment, regulatory, and academic organizations, the meeting will explore how to demonstrate clinical efficacy, navigate evolving regulatory expectations, strengthen manufacturing strategies, and rebuild investor confidence in the microbiome field.

Join experts from organizations including Ferring Pharmaceuticals, Vedanta Biosciences, Nestlé Health Science, MRM Health, and The Gates Foundation to shape the future of live biotherapeutics and microbiome innovation.

Download the full event guide to learn more about the agenda, speakers, networking opportunities, and how you can get involved.

Extractables & Leachables Europe 2026

09th November 2026 - 11th November 2026

Europe’s leading conference dedicated to the science, testing, and regulatory landscape of extractables and leachables (E&L) in pharmaceuticals and medical devices.

Organised by Smithers, this event brings together CEOs, senior scientists, toxicologists, and R&D leaders from across the E&L supply chain.

Key 2026 themes include AI and digital transformation in E&L, advanced analytical chemistry, toxicological risk assessment, single-use systems, and medical device combination products.

With pre-conference workshops on 9 November and a two-day main programme, attendees gain the latest insights, regulatory updates, and networking.

Register with code BIOPHARMA10 for 10% off.

9th RNA-Targeted Drug Discovery & Development Summit 2026

10th November 2026 - 12th November 2026

The 9th RNA-Targeted Drug Discovery & Development Summit is the industry’s only dedicated forum focused exclusively on advancing RNA-targeted small molecules.

Taking place in Boston on November 10–12, 2026, the summit will unite 80+ leaders from biotech, pharma and academia to explore the latest breakthroughs in RNA target selection, structure-guided design, direct RNA binding, splice modulation, RNA degradation and translational development.

Featuring expert speakers from organizations including PTC Therapeutics, AstraZeneca, Sanofi, ReviR Therapeutics and Remix Therapeutics, the event provides a unique platform to share data, tackle discovery challenges and accelerate the development of next-generation RNA-targeted medicines.

 2nd World RNA-Based Therapeutic & Vaccine Summit South Korea 2026

10th November 2026 - 12th November 2026

Driven by South Korea’s government making strategic investments in mRNA platforms and growing collaboration between global pharma and local biotech innovators, the field is experiencing renewed development momentum. This is placing the region as a key hotspot for global mRNA innovation and interest.

Uniquely positioned as the industry’s most comprehensive biopharma forum, the 2nd World RNA-Based Therapeutic & Vaccine Summit South Korea brings together global and local leaders to share first-hand insights into cutting-edge mRNA modalities, delivery technologies, and manufacturing excellence, to progress mRNA medicines to patients faster.

Join 90 leading players from large pharma including Sanofi, Eisai, and Meiji Seika Pharma to brand new biotechs such as Lemonex Bio, AceRNA Technologies, and BreezeBio to build future collaborations.

Global Biotechnology Summit 2026

11th November 2026 - 12th November 2026

Description: Global Biotech Summit is the UAE’s premier platform for biotechnology, life sciences, and healthcare innovation, bringing together global leaders, scientists, investors, policymakers, startups, and industry pioneers to shape the future of the sector.

Taking place on 11–12 November 2026 at ADNEC Marina, Abu Dhabi, the summit fosters collaboration, investment, and knowledge exchange across emerging areas including biopharmaceuticals, precision medicine, AI-driven drug discovery, cell and gene therapy, diagnostics, digital health, and biomanufacturing.

Through high-impact conferences, a world-class exhibition, startup showcases, and strategic networking opportunities, Global Biotech Summit accelerates partnerships, innovation, and commercialization across the regional and global biotechnology ecosystem.

Revive ME 2026

11th November 2026 - 12th November 2026

Revive ME is the Middle East’s premier global longevity and health technology summit, bringing together 2,000+ changemakers, 700+ global and regional brands, 500+ C-suite and senior leaders, 150+ exhibitors and sponsors, and 50+ media and supporting partners in Abu Dhabi.

Taking place on 11–12 November 2026 at ADNEC Marina, the event serves as a platform for healthcare leaders, researchers, innovators, investors, policymakers, and entrepreneurs to connect, collaborate, and accelerate the future of longevity.

Through thought-provoking discussions, breakthrough technologies, strategic partnerships, and networking opportunities, Revive ME is where the global longevity ecosystem comes together to shape the future of healthier, longer lives.

9th Lab Asset & Facility Management Summit 2026

10th November 2026 - 12th November 2026

As budgets tighten and scientific complexity grows, lab operations, facilities, asset management, engineering, and EHS leaders face increasing pressure to improve efficiency while accelerating research.

Returning to Boston, the 9th Lab Asset & Facility Management Summit is the only forum dedicated to the operational functions that enable science to happen.

Join 190+ senior leaders to explore practical strategies for optimizing asset performance, streamlining lab environments, strengthening cross-functional collaboration, and maximizing time back to science.

Through interactive discussions, real-world case studies, and peer-to-peer networking, you’ll gain actionable insights to build smarter, more resilient, and efficient research environments that support scientific innovation.

LSX Investival Showcase London 2026

16th November 2026 - 16th November 2026

LSX Investival Showcase London brings together biotech innovators, medtech pioneers, healthcare investors and corporate strategists from across Europe and beyond, creating a dynamic environment for investment discussions, partnering opportunities and business development.

For life science companies, the Investival Showcase London offers a valuable opportunity to build visibility with European and global market, pitch to active investors and build new connections through organised partnering and networking opportunities.

Taking place on the first day of London Life Science Week, it’s growing in size and scale. It’s the first and largest public event of the week, open to the wider life science community, and offers full partnering facilities to all attendees.

Biomarker Operations & Biospecimen Management Summit 2026

16th November 2026 - 17th November 2026

Standardize & Scale Biomarker Operations Across Increasingly Complex Trials to Prevent Critical Delays & Keep Studies On Track

For the very first time, the biomarker and biospecimen management community will have a forum solely dedicated to this rapidly expanding and increasingly critical function.

As trials expand globally and become more sample-intensive, protecting sample integrity and turning specimen data into trustworthy decisions has never mattered more. The inaugural Biomarker Operations & Biospecimen Management Summit provides a long-overdue home to share experiences and define the standards this field now demands.

Following the complete sample lifecycle, from kit design and site collection through to tracking, storage, biobanking, lab coordination, and data harmonization, attendees will gain practical insights to implement robust, scalable biomarker and biospecimen operations.

Join 80+ senior leaders from biopharma, labs, CROs, and biobanks united in ensuring every sample is treated with the precision, rigor, and care it requires.

Event Dates: November 16-17, 2026

Event Location: Hyatt Regency, One Ave de Lafayette, Boston, MA.

AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma 2026

16th November 2026 - 17th November 2026

The Marcus Evans AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma conference explores how pharma leaders are embedding Gen AI for long-term forecasting, Agentic AI for Real-World Evidence, and advanced analytics into cross-functional workflows, all under strong data and AI governance.

Through case studies, panels, roundtables, and workshops, attendees will gain practical insights on rare disease and lifecycle forecasting, scenario planning, forecasting agility in volatile therapy markets, healthcare data governance, and structuring enterprise AI and analytics functions.

Speakers include senior leaders from Novartis, UCB, BioMarin, CSL, Ferring Pharmaceuticals, Lundbeck, and many more of the most prestigious pharmaceutical companies.

BioPharmaAsia readers can benefit from a €200 discount! Enquire in our website for more registration information.

4th LNP Characterization & Analytical Development Summit 2026

18th November 2026 - 19th November 2026

The 4th LNP Characterization & Analytical Development Summit is the only industry-focused event dedicated to advancing the analytical and characterization capabilities needed to support the next generation of lipid nanoparticle (LNP)-enabled therapeutics.

Bringing together analytical development, characterization, formulation, and CMC leaders from across pharma and biotech, the meeting will explore innovative approaches to structural characterization, predictive critical quality attributes (CQAs), targeted LNP analytics, multi-attribute methods, and complex payload systems.

Through expert-led case studies, interactive discussions, poster presentations, and networking opportunities, attendees will gain practical insights to improve product quality, accelerate development timelines, and meet evolving regulatory expectations.

10th American Pharma Manufacturing & Outsourcing Summit 2026

19th November 2026 - 20th November 2026

The American Pharma Manufacturing & Outsourcing Summit is taking place November 19-20, 2026, in Boston, MA.

This pharma manufacturing and pharma outsourcing conference is designed to provide pharmaceutical executives with current trends, strategic insights, and best practices in manufacturing, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics.

This event brings together manufacturing and supply chain-focused leaders involved in pharmaceutical manufacturing and outsourcing.

Network with over 150 of your fellow pharma leaders as we explore strategies to maximize efficiency while remaining compliant in this ever-evolving environment.

Pharma Logistics & SCM Summit 2026

23rd November 2026 - 24th November 2026

Pharma Logistics & SCM Summit 2026 brings together pharmaceutical supply chain, logistics, distribution, quality, operations, and compliance leaders building more resilient pharma supply chains.

The event focuses on end-to-end visibility, risk management, regulatory compliance, digital supply chain tools, serialization, demand planning, distribution excellence, and global supply chain optimization.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October

Pharma Packaging & Labeling Summit 2026

23rd November 2026 - 24th November 2026

Pharma Packaging & Labeling Summit 2026 brings together packaging, labeling, artwork, regulatory, quality, serialization, and supply chain professionals focused on compliance and patient safety.

The event focuses on labeling accuracy, artwork management, serialization, anti-counterfeiting, smart packaging, sustainability, regulatory compliance, digital workflows, and packaging innovation.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma Cold Chain Summit 2026

23rd November 2026 - 24th November 2026

Pharma Cold Chain Summit 2026 brings together cold chain, logistics, supply chain, quality, packaging, and distribution professionals protecting temperature-sensitive pharmaceutical products.

The event focuses on real-time temperature monitoring, cold chain visibility, regulatory compliance, data-driven risk management, biologics, advanced therapies, ultra-low temperature logistics, and packaging innovation.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma TRACKTS 2026

23rd November 2026 - 24th November 2026

Pharma TRACKTS 2026 brings together track & trace, serialization, packaging, labeling, compliance, supply chain security, and digital transformation professionals.

The event focuses on serialization, aggregation, anti-counterfeiting, digital product passports, regulatory updates, data exchange, product authentication, supply chain visibility, and advanced tracking technologies.

Engage with 500+ senior pharma professionals, 135+ sessions, 72+ real-world case studies, solution providers, and expert speakers in Berlin this October.

Pharma Flow Europe 2026

23rd November 2026 - 24th November 2026

Pharma Logistics & SCM Summit 2026, Pharma Packaging & Labelling Summit 2026, Pharma Cold Chain Summit 2026, and Pharma TRACKTS 2026 come together as one powerful pharma supply chain, packaging, cold chain, and traceability platform, taking place on November 23–24, 2026, at the Radisson Blu Hotel Frankfurt.

The co-located show brings together senior leaders from pharmaceutical logistics, supply chain management, packaging, labelling, cold chain, distribution, quality, regulatory affairs, serialisation, track & trace, and compliance.

The event focuses on supply chain visibility, temperature-controlled logistics, packaging innovation, labelling accuracy, serialization, aggregation, anti-counterfeiting, regulatory compliance, product integrity, and end-to-end pharmatraceability.

Engage with senior pharma professionals, solution providers, and expert speakers in Frankfurt this November. Register with code MKT10 to receive a 10% discount.

PharmaLab Congress and Exhibition 2026 at a new venue

23rd November 2026 - 25th November 2026

PharmaLab Congress and Exhibition will take place from 23–25 November 2026 at the darmstadtium in Darmstadt near Frankfurt Airport, a modern conference centre with state-of-the-art and sustainable technical facilities.

The event for all pharmaceutical laboratory sectors will cover various topics and lectures on analytics, bioanalytics and microbiology, providing opportunities to share knowledge and experience with regulators, industry experts and laboratory scientists.

Participants benefit from 9 parallel conferences, 3 pre-conference workshops, over 100 presentations, more than 60 exhibitors and the networking event.

Continue reading to find out more….

5th European Biomanufacturing Summit 2026

24th November 2026 - 25th November 2026

The European Biomanufacturing Summit is taking place November 24-25, 2026 in Dusseldorf, Germany.

The event is designed to provide biopharmaceutical and biomanufacturing executives with current trends in biotechnology and pharmaceuticals, advances in cell and gene therapy, and CMC pharmaceutical development.

The strategic insights regarding biotechnological developments, best practices in manufacturing, drug delivery, outsourcing, capacity management, quality assurance, quality control, regulatory compliance, operational excellence, supply chain, and logistics are among the topics that will be covered.

Novel CNS Biomarkers Summit Europe 2026

30th November 2026 - 02nd December 2026

The Novel CNS Biomarkers Summit Europe is the only European meeting dedicated exclusively to advancing fluid, imaging, and digital biomarkers for CNS drug development.

Bringing together biomarker, translational medicine, neuroscience, and clinical development leaders, the summit focuses on accelerating the discovery, validation, and implementation of next-generation biomarkers across neurodegenerative and neurological diseases.

Why Attend?

• Join 60+ biomarker and translational medicine leaders

• Gain insights from 17+ expert speakers

• Explore biomarker strategies across 6+ CNS indications

• Participate in interactive workshops and networking opportunities

• Learn from leading organisations including Roche, UCB, Lundbeck, Servier, and more

4th Cell Therapy for Autoimmune Disease Summit 2026

01st December 2026 - 03rd December 2026

Join the 4th Cell Therapy for Autoimmune Disease Summit, the leading industry forum dedicated to advancing next-generation cell therapies for autoimmune diseases.

Bringing together biotech, pharma, academic, and clinical leaders, this meeting explores the latest developments across CAR-T, Treg, NK, MSC, and emerging in vivo cell therapies.

Gain exclusive insights into clinical readouts, immune reset strategies, translational research, patient selection, manufacturing scalability, and commercialization pathways.

With expert speakers from leading innovators and dedicated tracks covering preclinical and clinical development, this is the essential event for those shaping the future of autoimmune cell therapy and immune-mediated disease treatment.

10th Anniversary Antifibrotic Drug Development Summit 2026

01st December 2026 - 03rd December 2026

The 10th Anniversary Antifibrotic Drug Development Summit returns to Boston as the only industry-focused forum dedicated to cross-indication antifibrotic drug development.

Bringing together 60+ senior leaders across discovery, preclinical, translational, biomarker, and early clinical development, the meeting explores how shared fibrosis mechanisms can accelerate innovation across organs and indications.

Through three interactive workshops and two conference days, attendees will examine fibrosis resolution, cross-tissue biology, human-relevant models, predictive biomarkers, patient stratification, and indication expansion strategies.

Join experts from leading organizations including AbbVie, Madrigal Pharmaceuticals, Arda Therapeutics, aTyr Pharma, and Vicore Pharma to gain practical insights, valuable connections, and confidence in advancing next-generation antifibrotic therapies.

Amylin-Based Therapeutics Summit 2026

01st December 2026 - 03rd December 2026

The inaugural Amylin‑Based Therapeutics Summit 2026 is the first and only industry‑dedicated forum bringing biopharma and academia together to dive deep and explore the full breadth of amylin drug development – from foundational receptor biology to late‑stage clinical strategy.

Across two immersive days, learn from and connect with pioneering minds from Novo Nordisk, Eli Lilly, Zealand Pharma, iBio, I2O Therapeutics and emerging innovators who are collectively shaping the field.

Continue reading for the full event guide

8th CNS Drug Delivery Summit 2026

01st December 2026 - 03rd December 2026

Long regarded as one of the greatest barriers to successful CNS drug development, brain delivery is entering a new era of clinical validation. Following FDA approval of Denali’s Avlayah and encouraging progress from Roche’s Trontinemab, the industry now has proof that blood-brain barrier (BBB) shuttle technologies can achieve meaningful CNS exposure for biologics.

This momentum is driving innovation across brain shuttles, targeted vectors, oligonucleotide delivery, focused ultrasound, intrathecal systems, and next-generation delivery platforms.

Despite this progress, key challenges remain, including improving brain exposure, demonstrating clinical translatability, optimising biodistribution, reducing toxicity risk, and scaling manufacturing.

As developers move beyond transferrin receptor targeting and explore novel BBB receptors, advanced imaging, humanised models, and innovative delivery approaches, collaboration is critical.

The 8th CNS Drug Delivery Summit brings together 100+ senior leaders across neuroscience, drug delivery, translational science, biologics, platform development, business development, and investment to accelerate the next generation of CNS therapeutics.

15th Tumour Models Summit London 2026

02nd December 2026 - 03rd December 2026

The 15th Tumour Models Summit London is Europe’s longest-standing and most comprehensive meeting dedicated to advancing preclinical and translational tumour modelling.

As oncology pipelines become increasingly dependent on immunotherapies, cell therapies, ADCs, radioligand therapies, and precision medicines, development teams face growing pressure to improve translational confidence, identify predictive models, and generate decision-grade evidence earlier in development.

Join leaders from Roche, AstraZeneca, Johnson & Johnson, Eli Lilly, Immunocore, Merck, Molecular Partners, ImmunoKey, and innovative oncology biotechs to explore how human-relevant models, NAMs, AI-enabled approaches, patient-derived systems, biomarkers, tumour microenvironment models, and integrated development strategies can improve candidate selection, predict clinical outcomes, and reduce late-stage attrition.

Whether your focus is model validation, safety prediction, tumour microenvironment biology, translational biomarkers, AI-driven prediction, or regulatory strategy, this is the industry’s definitive forum for improving oncology model translatability.

3rd Annual Personalized Cancer Vaccine Summit 2026

01st December 2026 - 03rd December 2026

The personalized cancer vaccine field has reached a defining milestone. With Moderna and Merck reporting positive initial Phase 3 data for intismeran autogene in combination with Keytruda, the first regulatory approval of a personalized neoantigen cancer vaccine is now firmly within sight, accelerating momentum across the entire industry.

Yet significant challenges remain. As innovation accelerates, organizations must overcome key challenges spanning development, manufacturing, delivery, and market access.

The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across Moderna, Medici Therapeutics, Geneos Therapeutics, Nykode Therapeutics, Echo Immune, HDT Bio, Mayo Clinic, Transgene, and more, to share data-driven insights, benchmark strategies and forge long-term partnerships for driving personalized cancer vaccines closer to approval.

13th Digital Pathology and AI Congress: Europe 2026

09th December 2026 - 10th December 2026

The 13th Digital Pathology and AI Congress: Europe 2026

The advances and applications of digital pathology; artificial intelligence and machine learning for primary diagnosis and clinical research

Date: 9th Dec 2026 to 10 Dec 2026

10th Complement-Based Drug Development Summit 2026

08th December 2026 - 10th December 2026

The 10th Complement-Based Drug Development Summit is the leading industry forum dedicated to advancing complement biology and therapeutic development.

The meeting brings together biopharma leaders, emerging biotech innovators, translational scientists, clinicians, and academic researchers to explore new opportunities across rare disease, inflammation, autoimmune disorders, nephrology, ophthalmology, neurology, and hematology.

Why Attend?

• Network with 80+ industry experts

• Learn from 25+ leading speakers

• Explore end-to-end complement drug development strategies

• Gain insights from 18+ data-driven presentations
• Participate in focused workshops and scientific discussions
• Learn from leading organizations including Regeneron, Genentech, Sanofi, Apellis and more.

World CNS Summit South Korea 2026

08th December 2026 - 10th December 2026

Korea is rapidly emerging as a global hub for CNS innovation, with breakthroughs spanning novel modalities, BBB shuttle technologies, and differentiated targets beyond Aβ and tau.

This momentum has attracted growing interest from pharma and investors alike, with major partnerships in 2026 including Fosun & AriBio, Insilico & SK Biopharmaceuticals, and Johnson & Johnson & Prazer Therapeutics, underscoring the significant opportunity to translate promising Korean assets into successful disease-modifying CNS therapies.

Against this backdrop of accelerating investment and innovation, the World CNS Summit South Korea will bring together leading Korean innovators including ABL Bio, AriBio, and ADEL, alongside global industry leaders such as Eli Lilly, Lundbeck, JCR Pharmaceuticals, and Novartis, to exchange insights, forge strategic partnerships, and advance the next generation of disease-modifying therapies for neurological disorders.

World Novel Drug Discovery Summit South Korea 2026

08th December 2026 - 10th December 2026

Through sustained government investment into AI and in silico capabilities, coupled with a culture that actively fosters collaboration and innovation, South Korea is rapidly emerging as a global hub for drug discovery excellence.

Prominent partnerships from companies like 1st Biotherapeutics, Galux, Pharos iBio and SK Biopharmaceuticals, are demonstrating how differentiated platforms, strategic partnerships, and novel approaches to R&D can position Korea alongside established biopharma leaders including the US and China.

The World Novel Drug Discovery Summit South Korea is the first and only industry-led forum empowering K-Bio to accelerate innovation and strengthen its position as a globally recognized and competitive drug discovery powerhouse.

Under the theme of accelerating future best-in-class platforms for next-generation modalities by integrating AI for smarter, faster and de-risked drug discovery, this inaugural forum will bring together 100+ K-Bio innovators, international pharma leaders and industry-renowned service providers to dive into cutting-edge technologies, proven drug discovery strategies, and collaborative networking opportunities to drive platform development and position K-Bio for global partnering and licensing opportunities.

3rd Obesity & Weight Loss Drug Development Summit West 2026

09th December 2026 - 10th December 2026

Optimizing Tolerability, Quality of Weight Loss & Personalized Therapies to Drive Competitive Drug Development

As obesity drug development enters a defining new chapter, the race is no longer about developing the next GLP-1, but delivering the next breakthrough in tolerability, muscle preservation, patient adherence, precision medicine, and long-term outcomes.

With hundreds of obesity assets in development and billions invested in the space, 2026 is a pivotal moment for companies to differentiate their pipelines and benchmark their strategies.

The 3rd Obesity & Weight Loss Drug Development Summit West is where pharma and biotech leaders come together to answer the questions shaping the next decade of obesity therapeutics. This summit is dedicated to the practical challenges and strategic decisions driving drug development success.

Bringing together 80+ senior executives and decision-makers, this intimate forum offers opportunities to exchange insights, build meaningful partnerships, and understand what today’s innovation really means for tomorrow’s therapies.

5th Ophthalmic Drug Delivery Summit 2027

19th January 2027 - 21st January 2027

The 5th Ophthalmic Drug Delivery Summit is where the innovators behind the next generation of ocular therapies come together to solve one critical challenge: getting the right therapy to the right place in the eye.

Hear directly from leaders at Kodiak Sciences, Re-Vana Therapeutics, Ripple Therapeutics, Eli Lilly, Genentech, Sanofi, Astellas, Apellis, Beacon Therapeutics, Kriya Therapeutics and more as they share the latest thinking on long-acting therapies, novel delivery routes, gene and cell therapy, translational science and drug-device integration.

Explore how methods to extend ocular exposure through, progress innovative techniques to progress sustained delivery and sustained-release implants through conventional intravitreal injection.

Expect candid lessons, emerging strategies and cross-functional perspectives spanning delivery, formulation, devices, CMC, clinical development, regulatory strategy and commercialization.

Muscular Disorders Drug Development Summit 2027

26th January 2027 - 28th January 2027

After a year marked by uncertainty around Sarepta’s Elevidys, the field is on the verge of new era shaped by cross-modality innovation and meaningful progress, with FDA submissions anticipated from Regenxbio, Capricor and Avidity that could transform therapeutic options for muscular dystrophies.

With investments including Servier’s $2.65 billion buyout of Edgewise signposting reignited pharma interest and funding opportunities, muscle disease drug developers are poised to double down on investments across their preclinical, translational and clinical programs in 2026 and beyond.

Take advantage of this timely opportunity to join 60+ industry experts spanning muscle disease biology, translation, clinical development and more at the Muscular Disorders Drug Development Summit for three days of focused collaboration designed to:

• Explore emerging modalities beyond gene therapy

• Discover lessons learnt from developers of approved drugs

• Enhance biomarker measurements of muscular function and activity

• Innovate more targeted delivery to specific muscles while avoiding off-target tissues
• Leverage real-world data to uncover patient-relevant endpoints

With momentum building, don’t miss your chance to learn from Servier, Dyne Therapeutics, Sanofi, Biogen, Avidity Biosciences and more at the only forum dedicated to addressing biopharma’s most pressing challenges in advancing novel therapies for muscular dystrophies, Pompe disease and related myopathies.

TIDES Asia 2027

24th February 2027 - 26th February 2027

TIDES Asia is Asia’s premier biopharmaceutical conference focused on advancing oligonucleotide and peptide therapeutics.

It brings together 375+ attendees, 60+ industry speakers, and 40+ sponsors to share cutting-edge strategies in discovery, development, CMC, mRNA therapeutics, and genome editing.

The event features 2 workshops and 2 specialized tracks for the Asia-Pacific region.

World EPA Congress Europe 2027

02nd March 2027 - 03rd March 2027

The World Evidence, Pricing and Access (World EPA) Congress Europe 2027 will take place from March 2–3, 2027, at the RAI Congress Centre in Amsterdam.

As Europe’s largest annual gathering for market access, pricing, and health economics, the congress will feature over 1,600 delegates, 250 expert speakers, and 120 exhibitors.

Spanning 10 focused content tracks, the event addresses critical topics including healthcare reimbursement, rare diseases, HTA/payer dynamics, digital transformation, and real-world evidence.

Global pharmaceutical leaders and policymakers will convene to share cutting-edge strategies, optimize launch pathways, and explore innovative funding models to ensure sustainable patient access to medical innovation.

World Vaccine Congress Washington 2027

08th March 2027 - 11th March 2027

The World Vaccine Congress Washington 2027 returns March 8 – 11 at the Walter E. Washington Convention Center. As the most established global vaccine event, it covers the entire value chain from basic research to commercial manufacture.

The congress will gather 3,000 senior industry experts, 400 leading speakers, and 200 innovative exhibitors to drive progress in global health.

Key tracks include pandemic preparedness, clinical trials, bioprocessing, cancer immunotherapy, and equitable vaccine access.

Attendees will experience top presentations, strategic panel debates, and extensive networking opportunities. Join science, government, and manufacturing leaders to help shape the future of global disease eradication worldwide.

Gain an exclusive extra 20% off with code BPA20

17th World ADC London 2027

08th March 2027 - 11th March 2027

The preliminary agenda for the 17th World ADC London is now live, showcasing the latest scientific advances and strategic developments shaping the next generation of antibody-drug conjugates.

Taking place from 8-11 March 2027, the event will unite 700+ ADC leaders to address key challenges across discovery, translational research, clinical development and manufacturing.

With ADC developers focused on overcoming resistance mechanisms, improving therapeutic windows, enhancing linker-payload technologies and advancing novel target selection, the programme will deliver critical insights from 90+ industry experts.

Covering the full development pathway, attendees will gain access to emerging data, case studies and practical strategies designed to accelerate the development of safer, more effective ADC therapies.

View the preliminary agenda to explore the science driving the future of ADC innovation.

TIDES USA 2027

26th April 2027 - 29th April 2027

TIDES USA is a leading conference held in Boston dedicated to oligonucleotide and peptide therapeutics.

With 2000+ attendees, 200+ industry speakers, and 170+ sponsors, it covers research, development, manufacturing, drug delivery innovations, and regulatory considerations.

The event offers 8 workshops and 5 tracks, providing extensive networking opportunities for life sciences professionals.

World EPA Congress USA 2027

14th September 2027 - 15th September 2027

The World Evidence, Pricing and Access Congress USA officially launches September 14–15, 2027, in Boston, establishing America’s leading forum for pharma, biotechs, payers, and HTA bodies.

This inaugural event tackles the critical friction points in healthcare delivery: balancing innovative therapy costs with sustainable patient access. Attendees will dive into real-world evidence (RWE) integration, navigating complex US pricing frameworks, and optimizing global market entry strategies.

Featuring interactive panels and presentation tracks, extensive solution-provider exhibitions, and limitless networking opportunities across two full days, the congress bridges the gap between clinical data and commercial viability – shaping the future of equitable, evidence-based healthcare access.